Skip Navigation
 
Home | About CDC | Media Relations | A-Z Index | Contact Us
  
Centers for Disease Control and Prevention
CDC en Español 
 

Sexually Transmitted Diseases

Home  /  Surveillance  /  2003 Reports  /
Tables
Tables
  Syphilis

 << Previous Table of Contents Next >> 

Table 22.

All stages of syphilis — Reported cases and rates by state/area and region listed in alphabetical order: United States and outlying areas, 1999–2003
Table 23. All stages of syphilis — Reported cases and rates in selected cities listed in alphabetical order: United States and outlying areas, 1999–2003
Table 24. Primary and secondary syphilis — Reported cases and rates by state/area, ranked by rates: United States, 2003
Table 25. Primary and secondary syphilis — Counties and independent cities ranked by number of reported cases: United States, 2003
Table 26. Primary and secondary syphilis — Reported cases and rates by state/area and region listed in alphabetical order: United States and outlying areas, 1999–2003
Table 27. Primary and secondary syphilis — Women – Reported cases and rates by state/area and region listed in alphabetical order: United States and outlying areas, 1999–2003
Table 28. Primary and secondary syphilis — Men – Reported cases and rates by state/area and region listed in alphabetical order: United States and outlying areas, 1999–2003
Table 29. Primary and secondary syphilis — Reported cases and rates in selected cities, ranked by rates: United States, 2003
Table 30. Primary and secondary syphilis — Reported cases and rates in selected cities listed in alphabetical order: United States and outlying areas, 1999–2003
Table 31. Primary and secondary syphilis — Women – Reported cases and rates in selected cities listed in alphabetical order: United States and outlying areas, 1999–2003
Table 32. Primary and secondary syphilis — Men – Reported cases and rates in selected cities listed in alphabetical order: United States and outlying areas, 1999–2003
Table 33. Primary and secondary syphilis — Reported cases and rates per 100,000 population by age and sex: United States, 1999–2003
Table 34A. Primary and secondary syphilis — Reported cases by race/ethnicity, age group and sex: United States, 1999–2003
Table 34B. Primary and secondary syphilis — Rates per 100,000 population by race/ethnicity, age group and sex: United States, 1999–2003
Table 35. Early latent syphilis — Reported cases and rates by state/area and region listed in alphabetical order: United States and outlying areas, 1999–2003
Table 36. Early latent syphilis — Reported cases and rates in selected cities listed in alphabetical order: United States and outlying areas, 1999–2003
Table 37. Late and late latent syphilis — Reported cases and rates by state/area and region listed in alphabetical order: United States and outlying areas, 1999–2003
Table 38. Late and late latent syphilis — Reported cases and rates in selected cities listed in alphabetical order: United States and outlying areas, 1999–2003
Table 39. Congenital syphilis — Reported cases and rates in infants <1 year of age: United States (excluding outlying areas), 1963–2003
Table 40. Congenital syphilis — Reported cases and rates in infants <1 year of age by state, ranked by rates: United States, 2003
Table 41. Congenital syphilis — Reported cases and rates in infants <1 year of age by state/area and region listed in alphabetical order: United States and outlying areas, 1999–2003
Table 42. Congenital syphilis — Reported cases and rates in infants <1 year of age in selected cities, ranked by rates: United States, 2003
Table 43. Congenital syphilis — Reported cases and rates in infants <1 year of age in selected cities listed in alphabetical order: United States and outlying areas, 1999–2003
 Table 44.

Congenital syphilis — Reported cases and rates in infants <1 year of age by race/ethnicity of mother, 1999–2003

 

 << Previous Table of Contents Next >> 

Page last modified: November 15, 2004
Page last reviewed: November 15, 2004 Historical Document

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention